Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, March 19, 2026

Type 1 Diabetes Linked to Threefold Increase in Dementia Risk

 

Your competent? doctor needs to know everything about diabetes prevention because this:

People with diabetes have a higher risk of stroke, and stroke can also lead to new or worsening diabetes.  

Type 1 Diabetes Linked to Threefold Increase in Dementia Risk

Study highlights rising dementia concerns as type 1 diabetes patients live longer

Key Takeaways

  • Older people with type 1 diabetes had a nearly threefold higher risk of dementia compared with those without diabetes.
  • Type 1 diabetes may present a unique set of dementia risks, in part due to the autoimmune destruction of beta cells.
  • As people with type 1 diabetes are living longer, researchers underscored the need for better dementia prevention.

Older adults with type 1 or type 2 diabetes had a higher risk of dementia, a U.S. prospective cohort study found.

Compared with people without diabetes, older adults with type 1 diabetes had a nearly threefold higher risk for incident all-cause dementia (HR 2.82, 95% CI 2.28-3.48) over a 2.4-year follow-up period, after adjusting for sociodemographic factors. Those with type 2 diabetes had a roughly twofold increased risk (HR 2.08, 95% CI 1.87-2.31).

An estimated 64.5% of dementia cases in people with type 1 diabetes could be attributed to the condition, Jennifer Weuve, MPH, ScD, of Boston University School of Public Health, and colleagues reported in Neurology.

"We have known that type 2 diabetes is linked to an increased risk of dementia, but this new research suggests that, unfortunately, the association may be even stronger for those with type 1 diabetes," Weuve explained in a statement.

"As advances in medical care have extended the lives of people with type 1 diabetes, it's becoming increasingly important to understand the relation of type 1 diabetes to the risk of dementia," she added.

"Type 1 diabetes is not common, so this condition accounts for a small fraction of all dementia cases," Weuve pointed out. "But for the growing number of people with type 1 diabetes who are over 65 years old, these findings underscore the urgency of understanding the ways in which type 1 diabetes influences dementia risk and how we can prevent or delay it."

There has been "vast evidence amassed" linking diabetes and dementia risk, but few studies have quantified the risk in type 1 diabetes, the researchers noted.

"Our findings regarding type 2 diabetes are consistent with previous literature," they wrote. Type 2 diabetes is tied to dementia risk through several mechanisms including hyperglycemia, increased beta-amyloid deposition, or comorbidities such as metabolic syndrome, hyperinsulinemia, or stroke, they explained.

In type 1 diabetes, however, hypoglycemic events may drive dementia risk by causing neuronal damage through altered glucose metabolism, insulin insufficiency, or oxidative stress and inflammation in the hippocampus.

"Although type 2 diabetes entails insulin resistance and hyperglycemia, type 1 diabetes may present a unique set of risks, in part due to the autoimmune destruction of beta cells," Weuve's team noted. "These mechanisms should be further explored."

Data came from the ongoing longitudinal All of Us cohort which was started in 2017. The analysis included 283,772 participants: 5,442 individuals with type 1 diabetes, 51,511 with type 2 diabetes, and 226,819 without diabetes. Mean age was 64.6 years, 56.7% were women, 60.3% were non-Hispanic white, and 13.3% were Hispanic/Latino. Average body mass index was 29.83.

Diabetes and dementia diagnoses were determined through electronic health record data. During follow-up, 2,348 participants developed dementia. All-cause dementia included Alzheimer's dementia, vascular dementia, and dementia of unknown etiology. Frontotemporal, Lewy body, or alcohol-related dementias weren't included.

Both women (HR 3.04, 95% CI 2.28-4.05) and men (HR 2.59, 95% CI 1.90-3.54) with type 1 diabetes had a higher risk for dementia compared with their counterparts who had no diabetes. All race and ethnic groups with type 1 diabetes also had significantly elevated dementia risks.

Weuve and co-authors acknowledged a potential surveillance bias. Because individuals with type 1 diabetes have more frequent contact with healthcare systems, they may have been more likely to receive an earlier dementia diagnosis than others.

Kristen Monaco
Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.
Disclosures

The study was funded by grants from the National Institutes of Health.

Weuve and co-authors reported no disclosures.

No comments:

Post a Comment